Santé Ventures has closed its largest fund to date, raising $330 million in committed capital for Fund V, surpassing its original $300 million target. The new fund will focus on investments in biotechnology, medical technology, and digital health companies, continuing the firm’s strategy of backing early-stage healthcare innovation.
Founded in 2006, Santé Ventures concentrates on startups tackling areas of high clinical complexity, capital inefficiency, or outdated care delivery models. Founding managing director and CIO Kevin Lalande said Fund V reinforces the firm’s mission to partner with entrepreneurs advancing breakthrough science and technology-driven healthcare solutions, with the goal of improving patient outcomes.
Santé now manages over $1 billion in capital and maintains a portfolio spanning value-based care, AI-enabled services, and healthcare automation. Current investments include Reimagine Care in oncology, OutcomesAI for AI-assisted clinical support, Rise Health in primary care analytics, CareHive in clinical navigation, and Graici, an agentic AI platform automating access to health and social services.
Click here to read the original news story.